Andrey Emanuilov Manov et al. 2021. Comparison of the effect on Hyperglycemia and the Adverse Effects among Different GLP-1 Receptor Agonists Added to Basal Insulin and between GLP-1 Receptor Agonists and Basal Insulin Versus Basal-Plus or Basal-Bolus Insulin in Type 2 Diabetes: A Meta-Analysis. New Frontiers in Medicine and Medical Research Vol. 10. (Aug. 2021), 147–163. DOI:https://doi.org/10.9734/bpi/nfmmr/v10/4105F.